[1]
“Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A single center Study”, Planet (Barisal), vol. 7, no. 01, pp. 255–266, Feb. 2024, Accessed: Oct. 26, 2024. [Online]. Available: https://bdjournals.org/index.php/planet/article/view/427